1.Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? Journal of Clinical Investigation. 2016;126:23.
2.Abraham E. New Definitions for Sepsis and Septic Shock: Continuing Evolution but With Much Still to Be Done. Jama. 2016;315:757.
3.Kotecha A, Vallabhajosyula S, Coville HH, Kashani K. Cardiorenal syndrome in sepsis: A narrative review. Journal of Critical Care. 2018;43:122–7.
4.Romerobermejo FJ, Ruizbailen M, Gilcebrian J, Huertosranchal MJ. Sepsis-induced Cardiomyopathy. Current Cardiology Reviews. 2011;7:163–83.
5.Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353.
6.Bo Z, Yue L, Jin-Sheng Z, Xiao-Hui Z, Wen-Jia C, Xin-Hua Y, et al. Cortistatin protects myocardium from endoplasmic reticulum stress induced apoptosis during sepsis. Molecular & Cellular Endocrinology. 2015;406:40–8.
7.Goodwin AJ, Guo C, Cook JA, Wolf BJ, Halushka PV, Fan H. Plasma levels of microRNA are altered with the development of shock in human sepsis: an observational study. Critical Care. 2015;19:440-.
8.Yao Y, Sun F, Lei M. miR–25 inhibits sepsis-induced cardiomyocyte apoptosis by targetting PTEN. Bioscience Reports. 2018;38.
9.Ling L, Zhang SH, Zhi LD, Li H, Wen QK, Li G, et al. MicroRNA–30e promotes hepatocyte proliferation and inhibits apoptosis in cecal ligation and puncture-induced sepsis through the JAK/STAT signaling pathway by binding to FOSL2. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2018;104:411.
10.Liu N, Jiao T, Huang Y, Liu W, Li Z, Ye X. Hepatitis B Virus Regulates Apoptosis and Tumorigenesis through the MicroRNA–15a-Smad7-Transforming Growth Factor Beta Pathway. Journal of Virology. 2015;89:2739–49.
11.Huijuan W, Pengjun Z, Weijun C, Dan F, Yanhong J, Lixin X. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients’ mortality: a prospective observational study. Plos One. 2012;7:e38885.
12.Wang X, Liu X, Xu J, Hou S, Zhang X, Ding Y. miR–15a/16 are upreuglated in the serum of neonatal sepsis patients and inhibit the LPS-induced inflammatory pathway. International Journal of Clinical & Experimental Medicine. 2015;8:5683–90.
13.Huijuan W, Pengjun Z, Weijun C, Dan F, Yanhong J, Li-Xin X. Evidence for serum miR–15a and miR–16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects. Clinical Chemistry & Laboratory Medicine. 2012;50:1423–8.
14.Hyung-Geun M, Jincheng Y, Yijie Z, Yang J. miR–15a/16 regulates macrophage phagocytosis after bacterial infection. Journal of Immunology. 2014;193:4558.
15.Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: Myocardial depression in sepsis and septic shock. Critical Care. 2002;6:500–8.
16.Apple FS, Murakami MM. Cardiac Troponin and Creatine Kinase MB Monitoring during In-Hospital Myocardial Reinfarction. Clinical Chemistry. 2005;51:460–3.
17.Zhai CS, Tang H, Liang YB, Chen ZB, Li ZY, Ma ZF. [Study of the effect of p53 and Bcl–2 protein expression in myocardial apoptosis in septic rats]. 2008;20:733.
18.Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective BCL–2 family inhibitors. Nature Reviews Drug Discovery. 2017;16:273–84.
19.Peckpalmer OM, Unsinger J, Chang K, Mcdonough JS, Perlman H, Mcdunn JE, et al. Modulation of the Bcl–2 family blocks sepsis-induced depletion of dendritic cells and macrophages. Shock. 2009;31:359–66.
20.Livak KJ ST. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T))Method. METHODS. 2001;Dec;25(4):402–8.
21.Kwon OK, Lee W, Kim SJ, Lee YM, Lee JY, Kim JY, et al. In-depth proteomics approach of secretome to identify novel biomarker for sepsis in LPS-stimulated endothelial cells. Electrophoresis. 2016;36:2851–8.
22.Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Evidence for serum miR–15a and miR–16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects. Clinical Chemistry and Laboratory Medicine. 2012;50:1423–8.
23.Wang X, Wang X, Liu X, Wang X, Xu J, Hou S, et al. miR–15a/16 are upreuglated in the serum of neonatal sepsis patients and inhibit the LPS-induced inflammatory pathway. International Journal of Clinical & Experimental Medicine. 2015;8:5683–90.
24.R I A, G A C, C M C. miR–15a and miR–16–1 in cancer: discovery, function and future perspectives. Cell Death and Differentiation. 2010;17:215.
25.Calin GA, Amelia C, Muller F, Manuela F, Wojcik SE, Masayoshi S, et al. MiR–15a and miR–16–1 cluster functions in human leukemia. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:5166–71.
26.Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF, et al. Overexpression of Bcl–2 in transgenic mice decreases apoptosis and improves survival in sepsis. Journal of Immunology. 1999;162:4148–56.
27.Wagner TH, Drewry AM, Macmillan S, Dunne WM, Chang KC, Karl IE, et al. Surviving sepsis: bcl–2 overexpression modulates splenocyte transcriptional responses in vivo. American Journal of Physiology Regulatory Integrative & Comparative Physiology. 2007;292:R1751.
28.Dandan HU, Lou L, Huilian XU. Effect of Shenfu Injection on the Cardiomyocyte Apoptosis and the Expression of Bcl–2 in Rat with Sepsis. Journal of Emergency in Traditional Chinese Medicine. 2015.
29.Nevière R, Marchetti P. Does Apoptosis Play a Role in the Development of Sepsis-Induced Myocardial Dysfunction? Update in Intensive Care & Emergency Medicine. 2002;38:124–36.
30.Hai-Yan Y, Jian-Rui W, Rui Z, Xiao-Ling Y, You-Feng Z, Wei-Jian L. Effect of glutamine on caspase–3 mRNA and protein expression in the myocardium of rats with sepsis. American Journal of the Medical Sciences. 2014;348:315.
31.Gonzalez GM, Selim MJ, Pizzo SV. GRP78: a multifunctional receptor on the cell surface. Antioxidants & Redox Signaling. 2009;11:2299–306.
32.Wei WY, Ma ZG, Zhang N, Xu SC, Yuan YP, Zeng XF, et al. Overexpression of CTRP3 protects against sepsis-induced myocardial dysfunction in mice. Molecular & Cellular Endocrinology. 2018;476.
33.Hardy B, Raiter A. Peptide-binding heat shock protein GRP78 protects cardiomyocytes from hypoxia-induced apoptosis. Journal of Molecular Medicine. 2010;88:1157–67.
34.Zang X, Chen W, Sheng B, Zhao L, Gu X, Zhen J, et al. [Predictive value of early phrase echocardiography and cardiac biological markers in patients with severe sepsis: a five-year single-center retrospective study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018;30:332–6.
35.Jain A, Sankar J, Anubhuti A, Yadav DK, Sankar MJ. Prevalence and Outcome of Sepsis-induced Myocardial Dysfunction in Children with ‘Sepsis’ ‘With’ and ‘Without Shock’-A Prospective Observational Study. J Trop Pediatr. 2018.
36.Hua H, Wang GD, Equipment DO, Hospital LT. Clinical value of combined detection of cTnI and CKMB in sepsis patients. Hainan Medical Journal. 2016.
37.Wu ZJ, Chen YF, Wang HD, Gao FH. [Expression of plasma miRNA–497 in children with sepsis-induced myocardial injury and its clinical significance]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. 2018;20:32.
38.Luo Y, Tan Z, Xinjun LI, Weili XU. Effect discussion of serum cTnI, CK-MB, NT-proBNP joint test in children with sepsis. China Modern Doctor. 2016.
39.Huang J, Liu S, Qunyan LE, Emergency DO. Clinical significance of serum procalcitonin and cardiac troponin I in patients with sepsis. China Modern Doctor. 2017.
40.Song Q, Fan R, Zhu H. Study on Myocardial Injury and Recovery of Clear Toxin Extract Liquid from Rats with Sepsis. Journal of Emergency in Traditional Chinese Medicine. 2018.